@article{ref1,
title="Driving under the influence of synthetic cannabinoid receptor agonist XLR-11",
journal="Journal of forensic sciences",
year="2014",
author="Lemos, Nikolas P.",
volume="59",
number="6",
pages="1679-1683",
abstract="The case of a 22-year-old male Caucasian driver is presented. He was involved in a traffic collision. At the roadside, he displayed blank stare and mellow speech with a barely audible voice. A DRE found low body temperature, rigid muscle tone, normal pulse, lack of horizontal and vertical gaze nystagmus, nonconvergence of the eyes, dilated pupil size, and normal papillary reaction to light. A standard toxicology DUID protocol was performed on the driver's whole blood including ELISA and GC-MS drug screens with negative results. Additional drug screening was undertaken for bath salts and synthetic cannabinoid receptor agonists by LC-MS/MS by a commercial laboratory and identified the synthetic cannabinoid receptor agonist XLR-11 in the driver's blood. XLR-11 was subsequently quantified at 1.34 ng/mL. This is the first documented case involving a driver operating a motor vehicle under the influence of the synthetic cannabinoid receptor agonist XLR-11.<p/> <p>Language: en</p>",
language="en",
issn="0022-1198",
doi="10.1111/1556-4029.12550",
url="http://dx.doi.org/10.1111/1556-4029.12550"
}